(CNNE) Cannae Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US13765N1072
Stock: Restaurants, Healthcare, Financial Services
Total Rating 16
Risk 67
Buy Signal -1.31
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.03% |
| Yield on Cost 5y | 1.46% |
| Yield CAGR 5y | 50.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.9% |
| Relative Tail Risk | -1.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.83 |
| Alpha | -37.75 |
| Character TTM | |
|---|---|
| Beta | 0.879 |
| Beta Downside | 1.002 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.79% |
| CAGR/Max DD | -0.39 |
Description: CNNE Cannae Holdings January 19, 2026
Cannae Holdings, Inc. (NYSE:CNNE) is a Las Vegas-based principal investment firm founded in 2014 that takes both minority and majority stakes across a diversified portfolio, notably in restaurants, technology-enabled healthcare services, and financial services.
Key metrics and sector dynamics to note: as of the most recent filing, CNNE’s market capitalization hovers around $150 million with a cash-rich balance sheet exceeding $200 million, giving it flexibility for opportunistic deals; the restaurant segment faces pressure from rising food-price inflation and labor costs, while technology-enabled healthcare is benefiting from a projected 12% CAGR through 2027 driven by telehealth adoption; financial services exposure aligns with a low-interest-rate environment that supports loan growth but could be vulnerable to rate hikes.
For a deeper, data-driven perspective on CNNE’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -466.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 0.32 > 1.0 |
| NWC/Revenue: 31.26% < 20% (prev 28.27%; Δ 2.99% < -1%) |
| CFO/TA -0.03 > 3% & CFO -40.6m > Net Income -466.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.7m) vs 12m ago -12.34% < -2% |
| Gross Margin: -2.91% > 18% (prev 0.03%; Δ -293.6% > 0.5%) |
| Asset Turnover: 22.64% > 50% (prev 20.20%; Δ 2.44% > 0%) |
| Interest Coverage Ratio: -17.22 > 6 (EBITDA TTM -222.7m / Interest Expense TTM 14.5m) |
Altman Z'' 0.38
| A: 0.09 (Total Current Assets 265.1m - Total Current Liabilities 130.6m) / Total Assets 1.51b |
| B: 0.08 (Retained Earnings 123.5m / Total Assets 1.51b) |
| C: -0.13 (EBIT TTM -249.7m / Avg Total Assets 1.90b) |
| D: 0.40 (Book Value of Equity 132.3m / Total Liabilities 331.6m) |
| Altman-Z'' Score: 0.38 = B |
Beneish M -3.92
| DSRI: 0.43 (Receivables 12.8m/32.0m, Revenue 430.2m/461.9m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.86 (AQ_t 0.71 / AQ_t-1 0.82) |
| SGI: 0.93 (Revenue 430.2m / 461.9m) |
| TATA: -0.28 (NI -466.3m - CFO -40.6m) / TA 1.51b) |
| Beneish M-Score: -3.92 (Cap -4..+1) = AAA |
What is the price of CNNE shares?
As of February 01, 2026, the stock is trading at USD 14.41 with a total of 324,432 shares traded.
Over the past week, the price has changed by -7.86%, over one month by -8.16%, over three months by -18.43% and over the past year by -24.92%.
Over the past week, the price has changed by -7.86%, over one month by -8.16%, over three months by -18.43% and over the past year by -24.92%.
Is CNNE a buy, sell or hold?
Cannae Holdings has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy CNNE.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CNNE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.5 | 42.3% |
| Analysts Target Price | 20.5 | 42.3% |
| ValueRay Target Price | 13.6 | -5.7% |
CNNE Fundamental Data Overview January 26, 2026
P/E Forward = 74.0741
P/S = 1.9042
P/B = 0.6683
Revenue TTM = 430.2m USD
EBIT TTM = -249.7m USD
EBITDA TTM = -222.7m USD
Long Term Debt = 61.7m USD (from longTermDebt, last quarter)
Short Term Debt = 22.1m USD (from shortTermDebt, last quarter)
Debt = 210.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.7m USD (from netDebt column, last quarter)
Enterprise Value = 795.5m USD (819.2m + Debt 210.1m - CCE 233.8m)
Interest Coverage Ratio = -17.22 (Ebit TTM -249.7m / Interest Expense TTM 14.5m)
EV/FCF = -16.10x (Enterprise Value 795.5m / FCF TTM -49.4m)
FCF Yield = -6.21% (FCF TTM -49.4m / Enterprise Value 795.5m)
FCF Margin = -11.48% (FCF TTM -49.4m / Revenue TTM 430.2m)
Net Margin = -108.4% (Net Income TTM -466.3m / Revenue TTM 430.2m)
Gross Margin = -2.91% ((Revenue TTM 430.2m - Cost of Revenue TTM 442.7m) / Revenue TTM)
Gross Margin QoQ = 5.80% (prev -15.25%)
Tobins Q-Ratio = 0.53 (Enterprise Value 795.5m / Total Assets 1.51b)
Interest Expense / Debt = 1.57% (Interest Expense 3.30m / Debt 210.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -197.3m (EBIT -249.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.03 (Total Current Assets 265.1m / Total Current Liabilities 130.6m)
Debt / Equity = 0.17 (Debt 210.1m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = 0.11 (negative EBITDA) (Net Debt -23.7m / EBITDA -222.7m)
Debt / FCF = 0.48 (negative FCF - burning cash) (Net Debt -23.7m / FCF TTM -49.4m)
Total Stockholder Equity = 1.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -24.54% (Net Income -466.3m / Total Assets 1.51b)
RoE = -30.34% (Net Income TTM -466.3m / Total Stockholder Equity 1.54b)
RoCE = -15.62% (EBIT -249.7m / Capital Employed (Equity 1.54b + L.T.Debt 61.7m))
RoIC = -11.71% (negative operating profit) (NOPAT -197.3m / Invested Capital 1.68b)
WACC = 7.54% (E(819.2m)/V(1.03b) * Re(9.15%) + D(210.1m)/V(1.03b) * Rd(1.57%) * (1-Tc(0.21)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -11.66%
Fair Price DCF = unknown (Cash Flow -49.4m)
EPS Correlation: -6.00 | EPS CAGR: 44.10% | SUE: 0.25 | # QB: 0
Revenue Correlation: -95.56 | Revenue CAGR: -13.22% | SUE: 0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.48 | Chg30d=-0.030 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.85 | Chg30d=-0.045 | Revisions Net=-1 | Growth EPS=+75.6% | Growth Revenue=-4.5%
P/S = 1.9042
P/B = 0.6683
Revenue TTM = 430.2m USD
EBIT TTM = -249.7m USD
EBITDA TTM = -222.7m USD
Long Term Debt = 61.7m USD (from longTermDebt, last quarter)
Short Term Debt = 22.1m USD (from shortTermDebt, last quarter)
Debt = 210.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.7m USD (from netDebt column, last quarter)
Enterprise Value = 795.5m USD (819.2m + Debt 210.1m - CCE 233.8m)
Interest Coverage Ratio = -17.22 (Ebit TTM -249.7m / Interest Expense TTM 14.5m)
EV/FCF = -16.10x (Enterprise Value 795.5m / FCF TTM -49.4m)
FCF Yield = -6.21% (FCF TTM -49.4m / Enterprise Value 795.5m)
FCF Margin = -11.48% (FCF TTM -49.4m / Revenue TTM 430.2m)
Net Margin = -108.4% (Net Income TTM -466.3m / Revenue TTM 430.2m)
Gross Margin = -2.91% ((Revenue TTM 430.2m - Cost of Revenue TTM 442.7m) / Revenue TTM)
Gross Margin QoQ = 5.80% (prev -15.25%)
Tobins Q-Ratio = 0.53 (Enterprise Value 795.5m / Total Assets 1.51b)
Interest Expense / Debt = 1.57% (Interest Expense 3.30m / Debt 210.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -197.3m (EBIT -249.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.03 (Total Current Assets 265.1m / Total Current Liabilities 130.6m)
Debt / Equity = 0.17 (Debt 210.1m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = 0.11 (negative EBITDA) (Net Debt -23.7m / EBITDA -222.7m)
Debt / FCF = 0.48 (negative FCF - burning cash) (Net Debt -23.7m / FCF TTM -49.4m)
Total Stockholder Equity = 1.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -24.54% (Net Income -466.3m / Total Assets 1.51b)
RoE = -30.34% (Net Income TTM -466.3m / Total Stockholder Equity 1.54b)
RoCE = -15.62% (EBIT -249.7m / Capital Employed (Equity 1.54b + L.T.Debt 61.7m))
RoIC = -11.71% (negative operating profit) (NOPAT -197.3m / Invested Capital 1.68b)
WACC = 7.54% (E(819.2m)/V(1.03b) * Re(9.15%) + D(210.1m)/V(1.03b) * Rd(1.57%) * (1-Tc(0.21)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -11.66%
Fair Price DCF = unknown (Cash Flow -49.4m)
EPS Correlation: -6.00 | EPS CAGR: 44.10% | SUE: 0.25 | # QB: 0
Revenue Correlation: -95.56 | Revenue CAGR: -13.22% | SUE: 0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.48 | Chg30d=-0.030 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.85 | Chg30d=-0.045 | Revisions Net=-1 | Growth EPS=+75.6% | Growth Revenue=-4.5%